Evidence map›Paper›PMID 33905102›Full record

ReviewHuman cell2021

The role of macrophages in anti-tumor immune responses: pathological significance and potential as therapeutic targets.

Hirotake Tsukamoto, Yoshihiro Komohara, Hiroyuki Oshiumi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Human cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Cells · 2023
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Cancer genomics & proteomics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hirotake TsukamotoDepartment of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Yoshihiro KomoharaDepartment of Pathology, Graduate School of Medical Sciences, Kumamoto University, Honjo 1-1-1, Chuo-Ku, Kumamoto, 860-8556, Japan. ycomo@kumamoto-u.ac.jp.ORCID http://orcid.org/0000-0001-9723-0846
Hiroyuki OshiumiDepartment of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Funding

Japan Society for the Promotion of Science 18K07325
6 · The paper itself

Abstract

Malignant tumors comprise various types of normal cells and tumor cells, and are infiltrated by large numbers of immune cells, including macrophages. The results of numerous studies on the function and significance of intratumoral macrophages (tumor-associated macrophages) suggest that these macrophages generally enhance tumor progression rather than act as anti-tumor immune agents. Although much remains unknown, in this review, we attempt to describe the role of macrophages in the tumor microenvironment, and discuss their potential mechanisms on the recent immunotherapy.

Indexed as

Molecular Targeted TherapyCell DifferentiationDisease ProgressionHumansImmune Checkpoint InhibitorsImmunotherapyMacrophage ActivationMacrophagesNeoplasmsTumor MicroenvironmentImmune Checkpoint InhibitorsCancerImmune responseMacrophagePD-L1TAM

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.